San Diego, CA, United States of America

Soraya Carrancio

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 9.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Soraya Carrancio

Introduction: Soraya Carrancio, based in San Diego, CA, is a prominent inventor known for her significant contributions to the field of pharmaceutical innovations. With a total of four patents to her name, her work exemplifies a dedication to advancing treatment options for critical health conditions.

Latest Patents: Soraya's latest patents include groundbreaking research on antiproliferative compounds aimed at treating conditions like multiple myeloma. One notable patent describes the compound 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, among other formulations and their pharmaceutical applications. Additionally, she has developed a patent for substituted 4-aminoisoindoline-1,3-dione compounds, focusing on their compositions and therapeutic methods.

Career Highlights: Soraya Carrancio has made remarkable strides in her career as an inventor. Her association with Celgene Corporation has afforded her the opportunity to work at the forefront of biomedical research, improving the lives of many through innovative pharmaceutical solutions.

Collaborations: Collaboration with esteemed colleagues such as Antonia Lopez-Girona and Paul Hollenbach has been pivotal in driving her innovative projects forward. Together, they have combined their expertise to push the boundaries of therapeutic development.

Conclusion: Soraya Carrancio represents the spirit of innovation in the pharmaceutical industry. Through her patents and collaborations, she continues to pave the way for advancements that have the potential to transform treatment methodologies for serious medical conditions. Her work reflects both her commitment to science and her desire to impact patient care positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…